Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia
- PMID: 33052516
- DOI: 10.1007/s10875-020-00881-9
Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia
Abstract
Background: Ataxia-telangiectasia (AT) is a rare genetic condition, caused by biallelic deleterious variants in the ATM gene, and has variable immunological abnormalities. This study aimed to examine immunologic parameters reflecting cell development, activation, proliferation, and class switch recombination (CSR) and determine their relationship to the clinical phenotype in AT patients.
Methods: In this study, 40 patients with a confirmed diagnosis of AT from the Iranian immunodeficiency registry center and 28 age-sex matched healthy controls were enrolled. We compared peripheral B and T cell subsets and T cell proliferation response to CD3/CD28 stimulation in AT patients with and without CSR defects using flow cytometry.
Results: A significant decrease in naïve, transitional, switched memory, and IgM only memory B cells, along with a sharp increase in the marginal zone-like and CD21low B cells was observed in the patients. We also found CD4+ and CD8+ naïve, central memory, and terminally differentiated effector memory CD4+ (TEMRA) T cells were decreased. CD4+ and CD8+ effector memory, CD8+ TEMRA, and CD4+ regulatory T cells were significantly elevated in our patients. CD4+ T cell proliferation was markedly impaired compared to the healthy controls. Moreover, immunological investigations of 15 AT patients with CSR defect revealed a significant reduction in the marginal zone, switched memory, and more intense defects in IgM only memory B cells, CD4+ naïve and central memory T cells.
Conclusion: The present study revealed that patients with AT have a broad spectrum of cellular and humoral deficiencies. Therefore, a detailed evaluation of T and B cell subsets increases understanding of the disease in patients and the risk of infection.
Keywords: B cell subsets; Primary immunodeficiency; T cell subsets; ataxia telangiectasia; class switch recombination (CSR); flow cytometry; proliferation assay.
Similar articles
-
A novel ATM mutation associated with elevated atypical lymphocyte populations, hyper-IgM, and cutaneous granulomas.Clin Immunol. 2019 Mar;200:55-63. doi: 10.1016/j.clim.2019.01.002. Epub 2019 Jan 9. Clin Immunol. 2019. PMID: 30639167 Free PMC article.
-
Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity.J Allergy Clin Immunol. 2013 May;131(5):1367-75.e9. doi: 10.1016/j.jaci.2013.01.053. Epub 2013 Apr 6. J Allergy Clin Immunol. 2013. PMID: 23566627
-
B-cell subsets imbalance and reduced expression of CD40 in ataxia-telangiectasia patients.Allergol Immunopathol (Madr). 2018 Sep-Oct;46(5):438-446. doi: 10.1016/j.aller.2017.09.031. Epub 2018 May 5. Allergol Immunopathol (Madr). 2018. PMID: 29739685
-
Cutaneous Granulomatosis and Class Switching Defect as a Presenting Sign in Ataxia-Telangiectasia: First Case from the National Iranian Registry and Review of the Literature.Immunol Invest. 2020 Aug;49(6):597-610. doi: 10.1080/08820139.2019.1692864. Epub 2019 Nov 25. Immunol Invest. 2020. PMID: 31762358 Review.
-
Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up.Clin Rev Allergy Immunol. 2017 Aug;53(1):14-27. doi: 10.1007/s12016-016-8568-1. Clin Rev Allergy Immunol. 2017. PMID: 27342459 Review.
Cited by
-
Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection.Immunity. 2023 Jun 13;56(6):1410-1428.e8. doi: 10.1016/j.immuni.2023.05.007. Epub 2023 May 16. Immunity. 2023. PMID: 37257450 Free PMC article.
-
B cells and T cells abnormalities in patients with selective IgA deficiency.Allergy Asthma Clin Immunol. 2023 Mar 20;19(1):23. doi: 10.1186/s13223-023-00775-6. Allergy Asthma Clin Immunol. 2023. PMID: 36941677 Free PMC article.
-
Infections and immune dysregulation in ataxia-telangiectasia children with hyper-IgM and non-hyper-IgM phenotypes: A single-center experience.Front Pediatr. 2022 Oct 20;10:972952. doi: 10.3389/fped.2022.972952. eCollection 2022. Front Pediatr. 2022. PMID: 36340711 Free PMC article.
-
CD21- CD27- Atypical B Cells in a Pediatric Cohort Study: An Extensive Single Center Flow Cytometric Analysis.Front Pediatr. 2022 Jun 3;10:822400. doi: 10.3389/fped.2022.822400. eCollection 2022. Front Pediatr. 2022. PMID: 35722474 Free PMC article.
-
Analysis of Clinical and Genetic Characterization of Three Ataxia-Telangiectasia Pedigrees With Novel ATM Gene Mutations.Front Pediatr. 2022 May 2;10:877826. doi: 10.3389/fped.2022.877826. eCollection 2022. Front Pediatr. 2022. PMID: 35586824 Free PMC article.
References
-
- Amirifar P, Ranjouri MR, Yazdani R, Abolhassani H, Aghamohammadi A. Ataxia-telangiectasia: a review of clinical features and molecular pathology. Pediatr Allergy Immunol. 2019;30(3):277–88. - PubMed
-
- Waldmann TA. Immunological abnormalities in ataxia-telangiectasia. In: Harnden DG, Bridges BA, editors. Ataxia Telangiectasia. Sussex, John Wiley and Sons; 1982. p. 37–51.
-
- Bobba N, Kaplan MS. Immunodeficiency and infections in ataxia-telangiectasia. Pediatrics. 2005;116(Supplement 2):568.
-
- Moeini Shad T, Ranjouri MR, Amirifar P. ClinicalManifestations in Iranian Ataxia telangiectasia patients. Immunol Genet J. 2020;3(1):29–40.
-
- Chessa L, Piane M, Magliozzi M, Torrente I, Savio C, Lulli P, et al. Founder effects for ATM gene mutations in Italian Ataxia telangiectasia families. Ann Hum Genet. 2009;73(5):532–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
